Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-17 Sale | 2025-09-19 4:52 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. 10% Owner | 64,536 | $14.04 | $906,075 | 2,886,245 (Indirect) | View |
| 2025-09-15 Sale | 2025-09-17 12:34 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. 10% Owner | 2,726 | $14.03 | $38,235 | 2,950,781 (Indirect) | View |
| 2025-09-11 Sale | 2025-09-15 5:38 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. 10% Owner | 15,116 | $14.28 | $215,856 | 2,953,507 (Indirect) | View |
| 2025-09-02 Sale | 2025-09-04 10:52 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 14,083 | $14.04 | $197,725 | 2,968,623 (Indirect) | View |
| 2025-08-29 Sale | 2025-09-02 2:40 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 23,723 | $13.89 | $329,512 | 2,982,706 (Indirect) | View |
| 2025-08-26 Sale | 2025-08-27 5:45 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 400 | $13.83 | $5,532 | 3,006,429 (Indirect) | View |
| 2025-08-21 Sale | 2025-08-25 09:43 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 10,710 | $14.07 | $150,690 | 3,006,829 (Indirect) | View |
| 2025-05-20 Sale | 2025-05-22 6:22 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 11,419 | $12.71 | $145,135 | 3,017,539 (Indirect) | View |
| 2025-05-15 Sale | 2025-05-19 6:47 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 23,729 | $12.08 | $286,646 | 3,028,958 (Indirect) | View |
| 2025-05-13 Sale | 2025-05-15 5:54 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 1,330 | $12.17 | $16,188 | 3,052,687 (Indirect) | View |
| 2025-05-08 Sale | 2025-05-12 7:39 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 12,689 | $11.98 | $152,014 | 3,054,017 (Indirect) | View |
| 2025-05-07 Sale | 2025-05-08 10:17 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 1,366 | $12.19 | $16,652 | 3,066,706 (Indirect) | View |
| 2025-04-17 Sale | 2025-04-21 08:54 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 9,144 | $11.78 | $107,716 | 3,068,072 (Indirect) | View |
| 2025-04-15 Sale | 2025-04-17 4:11 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 1,700 | $11.92 | $20,264 | 3,077,216 (Indirect) | View |
| 2025-04-14 Sale | 2025-04-15 10:20 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 15,400 | $11.67 | $179,718 | 3,078,916 (Indirect) | View |
| 2025-04-10 Sale | 2025-04-14 12:33 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 30,156 | $11.14 | $335,938 | 3,094,316 (Indirect) | View |
| 2025-04-03 Sale | 2025-04-07 12:30 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 17,210 | $11.97 | $205,932 | 3,124,472 (Indirect) | View |
| 2025-04-01 Sale | 2025-04-03 5:22 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 46,723 | $12.34 | $576,754 | 3,141,682 (Indirect) | View |
| 2025-03-31 Sale | 2025-04-01 4:21 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 48,623 | $12.58 | $611,677 | 3,188,405 (Indirect) | View |
| 2025-03-27 Sale | 2025-03-31 12:07 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 36,524 | $13 | $474,961 | 3,237,028 (Indirect) | View |
| 2025-03-24 Sale | 2025-03-25 11:47 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 2,329 | $13.21 | $30,766 | 3,273,552 (Indirect) | View |
| 2025-02-26 Sale | 2025-02-27 10:09 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 200 | $13.62 | $2,724 | 3,275,881 (Indirect) | View |
| 2025-02-13 Sale | 2025-02-18 1:09 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 100 | $13.88 | $1,388 | 3,276,081 (Indirect) | View |
| 2025-02-12 Sale | 2025-02-13 7:45 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 36,536 | $13.75 | $502,370 | 3,276,181 (Indirect) | View |
| 2025-02-10 Sale | 2025-02-12 1:00 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 62,743 | $13.89 | $871,709 | 3,312,717 (Indirect) | View |
| 2025-02-03 Sale | 2025-02-05 10:39 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 5,911 | $14.04 | $83,013 | 3,375,460 (Indirect) | View |
| 2025-01-30 Sale | 2025-02-03 3:30 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 36,978 | $14.21 | $525,274 | 3,381,371 (Indirect) | View |
| 2025-01-29 Sale | 2025-01-30 10:57 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 11,674 | $14.12 | $164,837 | 3,418,349 (Indirect) | View |
| 2024-08-23 Purchase | 2024-08-27 2:46 pm | abrdn Life Sciences Investors | HQL | Maher Bill Director | 650 | $15.37 | $9,991 | 1,715 (Indirect) | View |
| 2024-07-16 Purchase | 2024-07-18 2:56 pm | abrdn Life Sciences Investors | HQL | DiMartino Rose Director | 1,000 | $15.53 | $15,530 | 1,000 (Direct) | View |
| 2024-06-26 Purchase | 2024-06-27 11:22 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 100 | $14.07 | $1,407 | 3,429,991 (Indirect) | View |